A case of Behćet's disease complicated by visceral Leishmaniasis and myelodysplasia: clinical considerations.
Sirianni
M C
MC
Barbone
B
B
Monarca
B
B
Nanni
M
M
Laganà
B
B
Aiuti
F
F
D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000009:adverse effects; D001327:Autoimmune Diseases / Q000150:complications / Q000188:drug therapy; D001528:Behcet Syndrome / Q000150:complications* / Q000188:drug therapy*; D002699:Chlorambucil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D007898:Leishmaniasis, Visceral / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology; D008297:Male; D009190:Myelodysplastic Syndromes / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology
D018906:Antineoplastic Agents, Alkylating; D007166:Immunosuppressive Agents; D002699:Chlorambucil